YoVDO

HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution

Offered By: Labroots via YouTube

Tags

Cancer Research Courses Genomics Courses Biomarkers Courses Breast Cancer Courses Ovarian Cancer Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore homologous recombination deficiency (HRD) evaluation and scoring using the OncoScan CNV Assay in this informative webinar presented by Yann Christinat, PhD and Stephan Bartels, PhD. Learn about this whole-genome microarray research solution and its applications in identifying HRD as a genome-wide biomarker in high-grade ovarian and breast cancers. Discover how PARP inhibitors, a cancer therapeutic class, induce synthetic lethality in tumors with high levels of HRD. Gain valuable insights into the latest advancements in cancer research and potential therapeutic approaches during this 1-hour and 4-minute presentation.

Syllabus

HRD Evaluation and Scoring using OncoScan CNV Assay, a whole-genome microarray research solution


Taught by

Labroots

Related Courses

Introduction to Breast Cancer
Yale University via Coursera
Stratégies diagnostiques des cancers
Paris Diderot University via France Université Numerique
Electronic Systems for Cancer Diagnosis
Indian Institute of Science Bangalore via Swayam
Molecular Tumor Board 2020-21
University of Barcelona via Coursera
ON DEMAND: Yale’s Review of Advances in Oncology Highlights from the ASCO® Annual Meeting 2021
Yale University via Independent